Your browser doesn't support javascript.
loading
Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors.
Huang, Nana; Zhao, Chenchen; Hu, Xueyang; Zhang, Congjun; Xiong, Fuxing; Huang, Wei; Da, Liangshan; Shen, Yuanyuan; Wu, Hongyang.
Affiliation
  • Huang N; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhao C; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Hu X; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhang C; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xiong F; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Huang W; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Da L; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Shen Y; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Wu H; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Transl Cancer Res ; 11(1): 252-261, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35261901
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Cancer Res Year: 2022 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Cancer Res Year: 2022 Document type: Article Affiliation country: China Country of publication: China